FIELD: biotechnology.
SUBSTANCE: method of producing particles of bacteriophages of the Levivirus family and a method of biomineralization of these particles of bacteriophages of the Levivirus family are proposed.
EFFECT: invention can be used for targeted delivery of particles to malignant tumor cells enriched with integrin ανβ3, allowing to radically reduce their overall toxicity.
3 cl, 9 dwg, 4 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| THERAPEUTIC AGENT FOR TREATING VIRAL HEPATITIS C | 2014 |
|
RU2568872C1 |
| METHOD OF POLY-SIGNAL ACTIVATION OF MALIGNANT SOLID TUMORS CELL APOPTOSIS | 2015 |
|
RU2599462C1 |
| ONCOLYTIC TREATMENT METHOD FOR BREAST CANCER | 2018 |
|
RU2695136C1 |
| METHOD FOR PRODUCING BACTERIOPHAGE HPV AND METHOD FOR PRODUCING MODIFIED BACTERIOPHAGE HPV | 2022 |
|
RU2790451C1 |
| METHOD FOR OBTAINING VIRUS-LIKE PARTICLES OF NOROVIRUS CONTAINING THE PROTEIN VP1 OF ENTEROVIRUS ECHOVIRUS 30, IN VITRO | 2022 |
|
RU2789354C1 |
| CONJUGATES OF GHRELIN CARRIER | 2003 |
|
RU2325202C2 |
| VIRUS-LIKE PARTICLES WITH HIGH-DENSITY COATING FOR INDUCTION OF ANTIBODY EXPRESSION | 2017 |
|
RU2813282C2 |
| METHOD OF PRODUCING VIRUS-LIKE BACTERIOPHAGE PARTICLE | 2024 |
|
RU2821694C1 |
| VACCINES BASED ON VIRUS-LIKE PARTICLES (VLP) OF CANINE PARVOVIRUS (CPV) AND APPLICATION THEREOF | 2016 |
|
RU2710854C1 |
| ANTIGEN MATRIX FOR TREATMENT OF BONE DISEASE | 2002 |
|
RU2322258C2 |
